Product
Anti-CLL1 CART cells
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2024-12-05